Details for New Drug Application (NDA): 203623
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 203623
Tradename: | SILDENAFIL CITRATE |
Applicant: | Hetero Labs Ltd V |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Pharmacology for NDA: 203623
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 203623
Suppliers and Packaging for NDA: 203623
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 203623 | ANDA | Camber Pharmaceuticals, Inc. | 31722-776 | 31722-776-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-776-05) |
SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 203623 | ANDA | Camber Pharmaceuticals, Inc. | 31722-776 | 31722-776-31 | 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-776-31) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Nov 26, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription